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Background: Acinetobacter baumannii is an opportunistic pathogen, which has the ability to persist in the clinical
environment, causing acute and chronic infections. A possible mechanism contributing to survival of A. baumannii
is its ability to form a biofilm-like structure at the air/liquid interface, known as a pellicle. This study aimed to identify
and characterise the molecular mechanisms required for pellicle formation in A. baumannii and to assess a broad
range of clinical A. baumannii strains for their ability to form these multicellular structures.
Results: Random transposon mutagenesis was undertaken on a previously identified hyper-motile variant of A.
baumannii ATCC 17978 designated 17978hm. In total three genes critical for pellicle formation were identified;
cpdA, a phosphodiesterase required for degradation of cyclic adenosine monophosphate (cAMP), and A1S_0112
and A1S_0115 which are involved in the production of a secondary metabolite. While motility of the
A1S_0112::Tn and A1S_0115::Tn mutant strains was abolished, the cpdA::Tn mutant strain displayed a minor
alteration in its motility pattern. Determination of cAMP levels in the cpdA::Tn strain revealed a ~24-fold increase
in cellular cAMP, confirming the role CpdA plays in catabolising this secondary messenger molecule. Interestingly,
transcriptional analysis of the cpdA::Tn strain showed significant down-regulation of the operon harboring the
A1S_0112 and A1S_0115 genes, revealing a link between these three genes and pellicle formation. Examination
of our collection of 54 clinical A. baumannii strains revealed that eight formed a measurable pellicle; all of these
strains were motile.
Conclusions: This study shows that pellicle formation is a rare trait in A. baumannii and that a limited number of
genes are essential for the expression of this phenotype. Additionally, an association between pellicle formation
and motility was identified. The level of the signalling molecule cAMP was found to be controlled, in part, by the
cpdA gene product, in addition to playing a critical role in pellicle formation, cellular hydrophobicity and motility.
Furthermore, cAMP was identified as a novel regulator of the operon A1S_0112-0118.
Keywords: Cyclic AMP, Motility, Virulence, Biofilm, HydrophobicityBackground
Acinetobacter baumannii is an opportunistic Gram-
negative human pathogen that causes severe nosocomial
infections primarily in immune-compromised patients;
disease states include pneumonia, meningitis and bacter-
aemia [1–5]. The bacterium can be found in intensive care
units and is frequently isolated from medical devices
[6–9]. The capacity to survive in these environments is
possibly due to the ability of this organism to survive
desiccation and resist a broad spectrum of antibiotics* Correspondence: melissa.brown@flinders.edu.au
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creativecommons.org/publicdomain/zero/1.0/and disinfectants. As a result, A. baumannii has entrenched
itself in the clinical environment [10–12].
Given the occurrence of A. baumannii in intensive
care units and its high level of intrinsic and adapted re-
sistance, there is increased pressure to identify novel
drug targets. Therefore, understanding the molecular
mechanisms contributing to virulence in A. baumannii
is essential. Similar to numerous other organisms, A.
baumannii has the ability to grow a multicellular struc-
ture known as a biofilm (reviewed by Longo et al. 2014)
[13] of which the pellicle is a specialised form. The pel-
licle is localised to the interface between air and liquid,
and is a structure of connected cells surrounded by a
matrix of extracellular polymeric substance [14, 15]. Thecle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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cess in a stagnant environment to high levels of oxygen
and nutrients [16]. The pellicle can increase bacterial
survival under antibiotic pressure as well as contribute
to longer than usual persistence in a hostile environ-
ment, such as under drying conditions [17–19].
There are numerous molecular mechanisms poten-
tially involved in pellicle formation by A. baumannii.
One such mechanism is the csuA/BABCDE pilus
chaperone-usher assembly system which is responsible
for the production of pili and is essential in the forma-
tion of a biofilm on solid surfaces [2, 9, 20]. In a study
on Bacillus subtilis, 288 regulatory and potential regula-
tory genes were associated with pellicle formation [21].
Recent analyses of A. baumannii bacteria in the pellicle
state have revealed alterations in the expression of at
least 52 membrane proteins (32 up-regulated and 20
down-regulated) [22, 23]. These 52 proteins were found
to be involved in; iron uptake systems, lipid and car-
bohydrate transport, cellular metabolism, starvation, in
addition to porins and pili.
As bacteria encounter a wide range of environmental
conditions, there is a requirement to respond to these
changes, such as changing from a planktonic state to
living within a biofilm and/or pellicle; this can involve
deployment of a number of signalling molecules [24,
25]. Cyclic adenosine monophosphate (cAMP) is a
ubiquitous signalling molecule used in conjunction with
a variety of regulators for modulating gene expression
in both prokaryotes and eukaryotes [26, 27]. In bacteria,
it has been found to alter multiple virulence characteris-
tics. For example, in Vibrio cholerae cAMP has been
implicated in the regulation of cholera toxin, the toxin
co-regulated pilus and other pathogenic factors [28]. In
Serratia marcesens the importance of the cAMP recep-
tor protein (CRP complex) in the formation of biofilm
has been established [26]. In this case the type I
fimbriae-dependant biofilm is tightly regulated and a
deletion in the phosphodiesterase gene was found to in-
crease cAMP within the bacteria cell and consequently
decrease biofilm formation. Conversely, when increased
copies of the phosphodiesterase gene are introduced
into the bacterial cell, the bacteria enter into what is de-
scribed as a “hyper biofilm” state [26]. Similarly in
Pseudomonas aeruginosa, cAMP has been identified as a
key component in biofilm formation, where increased levels
of cAMP can inhibit adherence capabilities [29]. Further-
more, in this organism cAMP functions as a co-factor of
the virulence factor regulator Vfr, where the cAMP-Vfr
complex regulates type III secretion systems involved in
exporting toxins and other compounds [30–32]. This com-
plex also regulates virulence factors such as type IV pili, the
las quorum sensing system and exotoxin A [32, 33]. Al-
though a vfr-like gene is present in the A. baumanniigenome, its role in regulation of virulence factors and inter-
action with cAMP has not been reported.
The proteomic analyses by Marti et al. (2011) and Nait
Chabane et al. (2014) suggested that pellicle formation
in A. baumannii is not the result of a single gene or op-
eron [22, 23]. Instead, it is likely that pellicle formation
is multifactorial, requiring surface-exposed molecular
structures and an adequate level of transcriptional regu-
lation. The aim of this study is to provide insight into
the genetic elements that contribute to the ability of A.
baumannii to migrate to a surface and form a pellicle as
well as to assess the prevalence of pellicle formation in a
number of clinically-relevant A. baumannii strains.
Results and discussion
Pellicle formation is a rare trait in clinical A. baumannii
strains
In this study, we have defined the pellicle as a robust layer
of connected cells covering the surface of a liquid. To as-
sess the prevalence of pellicle formation, our collection of
clinical A. baumannii strains [34] was screened for this
phenotype. Pellicle formation was assessed using glass and
polypropylene tubes, as these materials are used for a
number of implements within the hospital environment
and have different surface properties, which may influence
the initial attachment and formation of a pellicle. Prelim-
inary assessment of pellicle biomass was conducted at
growth temperatures of 25 °C and 37 °C (data not shown),
which revealed that pellicle growth predominantly oc-
curred at 25 °C; these results coincide with Marti et al.
(2011) [35], as such, all subsequent analyses were per-
formed at 25 °C. Of the 54 clinical strains tested only eight
formed a robust pellicle, suggesting that this is not a ubi-
quitous phenotype (Table 1). These eight strains produced
varying amounts of total pellicle biomass when comparing
glass and polypropylene strata (Table 1). Pellicle formation
was categorised into three groups dependent on the
amount of pellicle material measured at OD600 where a;
“small pellicle” is considered >0.19, “moderate pellicle” is
considered >0.20 and <0.50 and “well-developed pellicle”
is >0.51. In glass tubes, strains ATCC 17978, 17978hm,
WM98c, 04145027 and AYE produced a well-developed
pellicle, while, AB0057, 11986752 and 2320495 produced
a moderate to small pellicle. Analysis in polypropylene
tubes showed that only two strains, 17978hm and
04145027, produced a strong pellicle, while four strains,
ATCC 17978, 11986752, 2320495 and WM98c, produced
a moderate to small pellicle. Both AYE and AB0057
formed a pellicle in glass tubes, but failed to form a meas-
urable pellicle in polypropylene tubes. Hence, the ability
to form a pellicle was not conserved across glass and poly-
propylene surfaces. These observed differences could be
due to a number of factors related to the specific adher-
ence strategies of each strain, such as the production of
Table 1 Pellicle formation in glass and polypropylene, cell hydrophobicity, motility status and isolation site
A. baumannii isolate Glass (OD600) Polypropylene (OD600) Hydrophobicity (%) Motility Isolation site
Pellicle forming A. baumannii strains
ATCC 17978 0.65 ± 0.16 0.44 ± 0.08 32 ± 0.25 + Meningitis
17978hm 1.03 ± 0.01 0.94 ± 0.02 42 ± 0.19 + Meningitis
11986752 0.13 ± 0.01 0.17 ± 0.04 98 ± 0.01 + Pus
2320495 0.35 ± 0.08 0.28 ± 0.06 98 ± 0.03 + Pus
WM98c 1.01 ± 0.02 0.37 ± 0.08 94 ± 0.10 + Unknown
04145027 0.62 ± 0.00 0.79 ± 0.04 100 ± 0.00 + Vaginal
AYE 0.65 ± 0.11 Not detected 92 ± 0.07 + Urinary
AB0057 0.47 ± 0.06 Not detected 0 + Blood
Surface film forming A. baumannii strains
6772166 BDa BD 0 + Pus
685775 BD BD 0 + Sputum
PW01c BD BD 0 + Unknown
6877889 BD BD 9 ± 0.09 + Sputum
6870155 BD BD 5 ± 0.07 + Sputum
a BD = below detection level
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of strains, 6772166, 6856775, PW01c, 6877889 and
6870155 produced a weak surface film that could not be
extracted using our protocol, attempts to do so by other
means such as draining the planktonic growth resulted in
destruction of this weak surface film. Structures such as
pilin-like proteins and exopolysaccharides have been
shown to be present in pellicles [23] and it is possible that
these structures are expressed at a reduced level in these
strains resulting in only a weak surface film. Interestingly,
all pellicle forming strains and those that formed a weak
surface film have been shown to be motile [34]. ThisFig. 1 Hydrophobicity of A. baumannii strains. Cell surface hydrophobicity
with a hydrophobic index above 70 % are shown in red, those above 30 %
no bar is visible are completely hydrophilic. The ability of each strain to for
hydrophobic index. Bars indicate the standard deviation of three separate efinding highlights the possibility that the molecular mech-
anisms involved in motility and pellicle formation are
linked.
Hydrophobicity across the clinical A. baumannii strains is
not directly linked to pellicle formation ability
In a number of bacterial species, including A. bauman-
nii, a positive association between cell surface hydropho-
bicity, biofilm formation and adherence capabilities has
been reported [36–38]. We evaluated our set of clinical
A. baumannii strains for cell surface hydrophobicity and
identified major differences (Fig. 1). Using the divisionswas assessed by the affiliation of the bacterial cell to xylene. Strains
are in purple and those below 30 % are in blue. Those strains where
m a pellicle in glass or polypropylene is shown as (+ or -) below the
xperiments
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(2011) [36], 42 of the strains displayed a hydrophilic
character, nine were found to have a strong hydrophobic
character and three showed an intermediate level of cell
surface hydrophobicity. Of the eight strains that formed
a pellicle in glass (Table 1), five (11986752, 2320495,
WM98c, 04145027 and AYE) were found to have a
strong hydrophobicity index of >70 %, two (ATCC
17978 and 17978hm) showed an intermediate hydropho-
bic character and AB0057 was found to be hydrophilic.
There are numerous proteins embedded within the outer
membrane of Gram-negative bacteria that have a variety
of functions including pili for adherence and possibly
pellicle formation as well as other physical characteris-
tics. Surface proteins can alter the surface chemistry of a
cell and affect the surface hydrophobicity [39, 40]. The
aforementioned results suggest a high level of correl-
ation between the ability to form an extractable pellicle
and an increase in cell surface hydrophobicity. The level
of hydrophobicity may have an influence on what sur-
face and how strongly bacteria interact due to a variety
of proteins on the cell surface [41, 42]. Interestingly, the
strains identified as producing a weak surface film all
show a hydrophilic nature.
A1S_0112, A1S_0115 and cpdA are essential for pellicle
formation in A. baumannii 17978hm
To further investigate the pellicle phenotype, we used
our previously characterised A. baumannii 17978hm
strain (harboring an insertion in hns) [43], which has the
ability to produce increased amounts of pellicle material
compared to the ATCC 17978 parent strain. This strain
was chosen as it allows good discrimination between the
pellicle and non-pellicle phenotype allowing ready iden-
tification in large scale screening procedures. To identify
genes associated with this potential virulence factor a
transposon bank of random mutants was constructed in
the 17978hm strain using the plasmid pLOF mini::-
Tn10:gfp:kan [44]. Approximately 4000 individual trans-
poson insertion mutants were examined in microtitre
trays for their ability to form a pellicle. Initial screening
identified nine transposon insertion mutants that were
incapable of pellicle formation. Subsequent evaluation of
these strains in polypropylene and glass tubes confirmed
the complete loss of the pellicle phenotype (data not
shown). The exact insertion site of the individual trans-
poson insertions were identified by cloning the kanamy-
cin resistance gene associated with the transposon
(mini::Tn10:gfp:kan) and subsequent sequencing. Inser-
tions were found to be within three genes: A1S_0249
(cpdA), a cAMP phosphodiesterase; A1S_0112, acyl-CoA
synthetase/adenosine monophosphate (AMP) acid ligase
II; and A1S_0115, which is annotated to be involved in
amino acid adenylation. The precise insertion site of thetransposon is given as the nucleotide position relative to
the A. baumannii ATCC 17978 genome sequence (Gen-
Bank CP000521) (Additional file 1). Seven transposon
insertions were identified to be within the A1S_0115
gene. A single representative of each of the three distinct
insertions, designated transposon mutants 1, 2 and 5,
was taken for further investigation (Additional file 1).
Transposon mutant 1 was identified as containing an
insertion within cpdA, cpdA::Tn. Bacteria finely modu-
late intracellular cAMP levels through adenylate cy-
clases (synthesis) and cAMP phosphodiesterases, such
as CpdA, which converts cAMP to AMP (degradation)
[45]. Therefore, as the insertional inactivation of cpdA
led to a loss of pellicle, this insertion identified the re-
quirement for cAMP regulation in this process. To con-
firm that the observed phenotype can be attributed to
disruption of cpdA, the cpdA::Tn mutant strain was
complemented by cloning a wild-type copy of cpdA
into the empty shuttle vector pWH1266 [46], produ-
cing pWH0249. The pWH0249 plasmid was subse-
quently electroporated into the cpdA::Tn mutant strain
generating the strain cpdA::Tn(0249) (Table 2). This
strain was found to successfully produce a pellicle in
contrast to both the cpdA::Tn mutant strain or the
cpdA::Tn control strain harboring the empty pWH1266
vector, cpdA::Tn(1266) (Table 2; Fig. 2).
Transposon mutant 2 A1S_0112::Tn and transposon
mutant 5 A1S_0115::Tn have insertions within the open
reading frame (ORFs) A1S_0112 and A1S_0115, which
are located in a large operon comprised of seven genes,
A1S_0112-0118 (Fig. 3). This operon has previously been
associated with cell motility, potentially by production
and secretion of a biosurfactant via a type-I secretion
system or another mechanism [47, 48]. A recent report
has shown that the genes within this operon are signifi-
cantly up-regulated in biofilm cells in A. baumannii
ATCC 17978 and a site-specific knockout of A1S_0114
abolished biofilm formation [49]. Efforts to complement
the A1S_0112::Tn and A1S_0115::Tn transposon mutant
strains with copies of the wild-type genes cloned into
pWH1266 (Table 2), were unsuccessful possibly due to
polar effects of the transposon insertions. In order to en-
sure that the lack of complementation was not due to a
lack of transcription of our complementing genes, we
undertook qRT-PCR that revealed adequate transcrip-
tion occurred for the wild-type A1S_0112 and A1S_0115
genes cloned into the empty pWH1266 vector (Table 3,
Additional file 2). As mentioned, pellicle formation was
not restored in these mutants, possibly because, these
ORFs are part of an operon which must be transcribed
as a polycistronic message making complementation of
these mutants not possible. This is supported by the work
of Clemmer et al. (2011) who previously isolated trans-
poson mutants in this region which abolished motility and
Table 2 A. baumannii 17978hm mutant derivatives constructed in this study
Abbreviated name Descriptiona
cpdA::Tn Tn10:gfp:kan insertion in cpdA, kanR
cpdA::Tn(0249) Tn10:gfp:kan insertion in cpdA containing pWH0249, kanR, ampR
cpdA::Tn(1266) Tn10:gfp:kan insertion in cpdA containing shuttle vector pWH1266, kanR, ampR, tetR
A1S_0112::Tn Tn10:gfp:kan insertion in A1S_0112, kanR
A1S_0112::Tn(0112) Tn10:gfp:kan insertion in A1S_0112 containing pWH0112, kanR, ampR
A1S_0112::Tn(1266) Tn10:gfp:kan insertion in A1S_0112 containing shuttle vector pWH1266, kanR, ampR, tetR
A1S_0115::Tn Tn10:gfp:kan insertion in A1S_0115, kanR
A1S_0115::Tn(0115) Tn10:gfp:kan insertion in A1S_0115 containing pWH0115, kanR, ampR
A1S_0115::Tn(1266) Tn10:gfp:kan insertion in A1S_0115 containing shuttle vector pWH1266, kanR, ampR, tetR
a kanR, kanamycin resistance at 50 μg/mL; ampR, ampicillin resistance at 100 μg/mL; tetR, tetracycline resistance at 12.5 μg/mL
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plement the mutants [47].
Characterisation of pellicle-deficient mutant strains
cpdA::Tn, A1S_0112::Tn and A1S_0115::Tn
The three transposon insertion mutant strains de-
scribed above were examined for potential growth per-
turbations in Luria-Bertani (LB) liquid cultures. All
three A. baumannii transposon mutant strains showed
comparable growth to the parent 17978hm strain
(Additional file 3), indicating that the loss of theA B C
Fig. 2 Pellicle formation by A. baumannii 17978hm parent,
cpdA::Tn(0249) and cpdA::Tn(1266) strains. A. baumannii strains were
grown in Luria-Bertani broth and analysed after a 72 h incubation at
25 °C in the absence of light. Pellicle material was assessed visually. (a)
17978hm parent strain; (b) cpdA::Tn(0249) complemented mutant strain
showing developed pellicles at the interface between the liquid and
air; and (c) cpdA::Tn(1266) mutant strain negative for pellicle
formation. Arrows identify the pellicle materialpellicle is not due to a general growth defect. Since
pellicle formation is only one type of biofilm, the abil-
ity to form a biofilm at the liquid-surface interface was
also examined. The three transposon mutants were
assessed for both their planktonic growth potential
and their ability to form a biofilm on polypropylene
(Fig. 4a and b). All transposon mutants showed an in-
crease in planktonic growth compared to the parent
and cpdA::Tn(0249) complemented derivative (p-value
<0.001) (Fig. 4a). The transposon insertion mutants were
able to form a significantly increased amount of biofilm in
polypropylene tubes compared to the parent strain
(cpdA::Tn, A1S_0115::Tn and A1S_0112::Tn; p-values of
0.05, 0.05 and 0.01, respectively) (Fig. 4b), while, the com-
plemented cpdA::Tn(0249) mutant strain returned the
phenotype to that of the parent (Fig. 4). Carriage of wild-
type copies of A1S_0112 and A1S_0115 in their respective
Tn mutant derivatives did not result in functional comple-
mentation (data not shown).
The three pellicle deficient transposon mutants all
displayed a >80 % reduction in cell surface hydro-
phobicity compared to the parent strain, to essentially
a hydrophilic nature (cpdA::Tn, A1S_0112::Tn and
A1S_0115::Tn; p-values of 0.001, 0.01 and 0.01, re-
spectively) (Fig. 5). This indicates that hydrophobicity
is affected when cpdA, A1S_0112 or A1S_0115 genes
are insertionally inactivated. The presence of the wild-
type cpdA gene in the A. baumannii cpdA::Tn(0249)
derivative not only complemented the hydrophobicity
character, but increased the hydrophobicity index to
60 % which is above the parent strain (p-value <0.001)
(Fig. 5); this would indicate that cAMP is involved in
modulating cell surface hydrophobicity. The increase
in hydrophobicity above the level seen with the parent
strain is likely due to a copy number effect of the
wild-type cpdA determinant residing on the pWH1266
plasmid.
Traditionally, A. baumannii has been considered non-
motile due to its lack of flagella; however, two forms of
Fig. 3 Operon with transposon insertion sites within A1S_0112 and A1S_0115 identified. The genetic organisation of the A1S_0112-0118 operon is
shown with the arrows representing open reading frames and depict the direction of transcription. The location of the transposon (Tn10) insertions in
A1S_0112 (green triangle) and A1S_0115 (blue triangle) are shown. Flanking genes illustrate the position of the operon within the chromosome
adjacent to the quorum sensing gene abaI, A1S_0110 hypothetical protein and A1S_0111 transcriptional regulator; the total size of the region shown
is 15,161 bp in length
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been described in this species [34, 50, 51]. While sliding
motility in non-flagellated bacteria can occur by surfac-
tant production in other bacteria [48], twitching motility
within A. baumannii is mediated by the extension and
retraction of type IV pili as a form of surface transloca-
tion [5]. We have shown previously that A. baumannii
strain 17978hm is motile via swarming on LB medium
containing 0.25 % agar [34]. Therefore, we applied these
conditions to examine the motility phenotypes of the
three pellicle-deficient transposon mutant strains. The
A1S_0112::Tn and A1S_0115::Tn mutant strains proved
to be non-motile as they only grew at the initial inocu-
lum site on the agar plate (Fig. 6). The A1S_0112::Tn
and A1S_0115::Tn mutant strains harboring either a
wild-type copy of A1S_0112 or A1S_0115 or an empty
vector pWH1266 also gave a negative result (Fig. 6). Our
data corroborate the findings by Clemmer et al. (2011)
[47], that the A1S_0112-0118 operon is required for mo-
tility as insertions within this operon were found to be
non-motile (Fig. 6). However, the loss of motility seen in
the transposon mutant strains is not universal becauseTable 3 Fold change in gene expression of transposon mutant
strains compared to the 17978hm parent strain
Strain A1S_0112* A1S_0115* A1S_0118*
cpdA::Tn -2.8 ± 0.21 ND ND
cpdA::Tn(0249) 1.5 ± 0.44 ND ND
cpdA::Tn(1266) -5.6 ± 0.032 ND ND
A1S_0112::Tn NA -335.46 ± 1.42 -28.44 ± 1.33
A1S_0112::Tn(0112) -0.49 ± 1.39 -669.37 ± 1.24 -51.63 ± 1.70
A1S_0112::Tn(1266) -171.25 ± 1.68 -325.53 ± 1.22 -85.43 ± 1.46
A1S_0115::Tn -1.14 ± 1.59 NA -83.29 ± 1.20
A1S_0115::Tn(0115) -4.1 ± 1.09 -1.16 ± 1.63 -28.97 ± 1.54
A1S_0115::Tn(1266) -0.99 ± 1.32 -347.29 ± 1.52 -72.50 ± 1.14
NA = not applicable
ND = not done
* = data from three biological replicatesthe cpdA::Tn variant remained motile despite presenting
a visually different motility pattern compared to the
17978hm parent strain (Fig. 6). The cpdA::Tn and
cpdA::Tn(1266) strains presented a spoke like motility
pattern, whereas the parent strain formed an even sur-
face film of motile cells. The cpdA::Tn(0249) mutant
strain returned the motility phenotype to that of the par-
ent covering the 0.25 % agar plate with motile bacterial
cells (Fig. 6). As such, motility was not substantially af-
fected, however the manner by which the bacterial cells
exercised their motility phenotype in the cpdA::Tn strain
was altered. These results connect the clinical A. bau-
mannii strains with the mutant derivatives of the
17978hm strain, in that, all pellicle forming strains in-
cluding those that form a weak surface film are motile
and when the pellicle is disrupted there is either an al-
teration in the motile phenotype as seen in the
cpdA::Tn mutant or complete abolishment of motility.
Bacterial adherence is a critical virulence factor and aids
in host and surface colonisation. The adherence of the A.
baumannii mutant strains to human lung epithelial cells
(A549) was assessed; all three transposon insertion strains
had adherence capabilities that were not significantly dif-
ferent to that of the 17978hm parent strain (data not
shown). This suggests that the mechanisms used by A.
baumannii for pellicle formation are not essential for ad-
herence to A549 human epithelial cells.
The levels of cAMP in the cpdA::Tn mutant strain are
significantly increased compared to the 17978hm parent
strain
The maintenance of intracellular cAMP levels is largely
a result of controlling cpdA expression [52]. Therefore,
if cpdA is inactivated, cAMP levels are expected to in-
crease in the bacterial cell. Quantification of cAMP
levels was achieved using a cyclic nucleotide XP enzymatic
immunoassay kit. The cpdA::Tn mutant strain was found
to have a level of cAMP approximately 24-fold greater
than in the 17978hm parent strain (0.5 nM and 12 nM,
AB
Fig. 4 Planktonic growth and biofilm formation in polypropylene tubes
of the transposon mutants and 17978hm parent strain. Cells were
cultured in Luria Bertani media without shaking at 37 °C in
polypropylene tubes for 72 h. (a) Planktonic growth was assessed by
removal of 1 mL of media and the optical density measured at OD600.
All three transposon insertion mutant strains showed a dramatic
increase of planktonic growth; 4-fold greater than the 17978hm parent
strain. Complementation of the cdpA mutation in the cpdA::Tn(0249)
strain returned the phenotype to wild-type levels. (b) The level of biofilm
produced was assessed by crystal violet staining. Transposon insertion
mutant strains had an increased biomass of the surface/liquid biofilm by
approximalty 30 % compared to that of the 17978hm parent. The
cpdA::Tn(0249) mutant strain that contains a wild-type copy of the gene,
restored the biofilm phenotype to that of the parent. Bars indicate the
standard deviation of three separate experiments. Asterisks indicate
significant difference: one denotes a p-value <0.05, two a p-value <0.01
and three a p-value <0.001, as determined by a student t-test
Fig. 5 Hydrophobicity index for A1S_0112::Tn, A1S_0115::Tn and
cpdA::Tn transposon insertion mutants. Hydrophobicity results were
obtained by assessing the bacterial cell affiliation to xylene. The
optical density of the cell suspension before (ODinital) and after
(ODfinal) the addition of xylene was measured at 600 nm. All the
transposon insertion mutant strains have reduced cell
hydrophobicity compared to the parental strain. The cpdA::Tn(0249)
mutant strain with a wild-type copy of cpdA has a hydrophobicity
greater than the 17978hm parent strain. Bars indicate the standard
deviation of three separate experiments. Asterisks indicate significant
difference: two denotes a p-value <0.01 and three a p-value <0.001,
as determined by a student t-test
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cpdA is involved in cAMP homeostasis within the cell and
that the disruption of this gene dramatically affects the ac-
cumulation of this secondary signalling molecule. Examin-
ation of cAMP levels in strains cpdA::Tn(0249) andcpdA::Tn(1266) showed that the phenotype could be spe-
cifically attributed to the inactivation of cpdA (Fig. 7).
Transcriptional profiling of the cpdA::Tn mutant strain
under motility conditions
To assess the association between pellicle formation
and motility qRT-PCR was undertaken on the A. bau-
mannii 17978hm parent and the cpdA::Tn transposon
mutant strain grown under previously identified motil-
ity conditions, i.e. on semi-solid LB agar [43]. Analysis
of the operon A1S_0112-0118 (Fig. 3) was undertaken
by quantifying the transcription of the A1S_0112 gene,
which is the first gene in the operon. In the cpdA::Tn
strain, the transcription level of A1S_0112 was 2.8-fold
down-regulated compared to the 17978hm parent (Table 3).
This indicated that CpdA via cAMP plays a role, either dir-
ectly or indirectly, in regulation of the A1S_0112-0118 op-
eron. This potential regulatory role of CpdA and cAMP on
the A1S_0112-0118 operon could explain the altered mo-
tility phenotype seen in the cpdA::Tn mutant strain, pos-
sibly due to alteration in the production of a biosurfactant
or through another unknown mechanism(s).
The A1S_0112-0118 operon described above has pre-
viously been shown to be activated by quorum-sensing
signals in the form of homoserine lactone (abaI,
A1S_0109) [47]. Furthermore, Saroj and Rather (2013)
have shown that down-regulation of abaI leads to a
A1S_0115::Tn          A1S_0115::Tn(1266)     A1S_0115::Tn(0115)       
A1S_0112::Tn           A1S_0112::Tn(1266)     A1S_0112::Tn(0112)    
cpdA::Tn                    cpdA::Tn(1266)              cpdA::Tn(0249)
ATCC 17978                   17978hm
Fig. 6 Motility of A. baumannii ATCC 17978, 17978hm, and transposon insertion mutants cpdA::Tn, A1S_0112::Tn and A1S_0115::Tn. Overnight grown
bacterial cells were used to inoculate Luria-Bertani media containing 0.25 % agar; plates were grown overnight at 37 °C. The A1S_0115::Tn, A1S_0115(0115)
and A1S_0115(1266) transposon mutant strains and the A1S_0112::Tn, A1S_0112::Tn(0112) and A1S_0112::Tn(1266) transposon mutant strains only show
growth at the initial inoculum site at the centre of the plate giving a non-motile phenotype. However, the cpdA::Tn, cpdA::Tn(0249) and cpdA::Tn(1266)
transposon mutant strains retained motility. The complemented strain cpdA::Tn(0249) displayed a motility pattern almost identical to the 17978hm parent,
whereas cpdA::Tn and cpdA::Tn(1266) displayed a “spoke-like” motility pattern. ATCC 17978 is included as a control displaying a non-motile phenotype
Giles et al. BMC Microbiology  (2015) 15:116 Page 8 of 14reduction in motility in A. nosocomialis strain M2
[53, 54]. Therefore, to examine whether the insertional
inactivation of cpdA in the cpdA::Tn mutant had a regu-
latory effect on the quorum sensing gene abaI when
grown on motility media, we assessed the levels of tran-
scription of abaI using qRT-PCR. The results revealed
that, despite the altered motility phenotype of the de-
rivative, abaI is expressed at a level comparable to the
parent strain (~1.2-fold increase). This suggests that the
A1S_0112-0118 operon is regulated independently by
two different factors; quorum-sensing (AbaI) and cAMP.Levels of cAMP act as one of the major signalling mole-
cules within the cell and have been show to regulate nu-
merous genes in other bacterial species such as P.
aeruginosa and Escherichia coli, possibly through activa-
tion of Vfr [33]. In P. aeruginosa, vfr is auto-regulated
and upon inactivation of cpdA, vfr expression increases
by 12-fold [33, 45]. We investigated this possibility in
our cpdA::Tn mutant strain by examining the transcript
of the putative vfr gene (A1S_1182). The qRT-PCR re-
sults showed a 1.7-fold decrease in vfr expression in the
cpdA::Tn mutant strain compared to the 17978hm
Fig. 7 Determination of intracellular cAMP levels. Bacterial cells were
grown to an OD600 of 0.7, disrupted and cAMP levels determined
using the Cyclic Nucleotide XP Enzymatic Immunoassay kit. The
amount of cAMP is given in nM representing a sample corresponding
to 1 mg of total cellular protein. Bars indicate the standard deviation of
three separate experiments. The cpdA::Tn transposon mutant has
12 mM of cAMP compared to the parent 17978hm strain which has
0.5 mM of cAMP within the cell. The cpdA::Tn(0249) mutant strain
returned the cAMP levels to that of the 17978hm parent strain. The
cpdA::Tn mutant strain harboring the empty vector pWH1266 had no
effect on the cAMP levels. Asterisks indicate significant difference
(p-value <0.001) as determined by one-way Anova
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to be statistically insignificant. Thus, although a 1.7-fold
reduction in vfr transcription was observed it is not
known whether cAMP and Vfr work in concert in A.
baumannii.Whole transcriptome analysis of the CpdA mutant
compared to the 17978hm A. baumannii parent strain
Alterations in the level of intracellular cAMP are known
to affect a plethora of phenotypes, including alterations
in metabolic processes, biofilm formation and cell surface
hydrophobicity [52]. Therefore, RNA sequencing was used
to investigate the transcriptome of the cpdA::Tn mutant
grown in Mueller Hinton broth, in order to assess the im-
pact high levels of cAMP have within the bacterial cell.
Transcriptome sequencing revealed that many genes were
differentially expressed in the cpdA::Tn mutant compared
to the parent. Of the approximately 3400 annotated genes
in ATCC 17978, 184 genes were more than 2-fold up-
regulated and 494 genes were more than 2-fold down-
regulated (Fig. 8). The most highly up-regulated gene is
identified as an alcohol dehydrogenase (A1S_1274) which
showed a 34-fold increase in expression, whereas the
greatest down-regulated gene is a putative transcriptional
regulator (A1S_1256) showing a 29-fold decrease of ex-
pression (Fig. 8).A number of the genes down-regulated in the
cpdA::Tn mutant include genes encoding phage-related
proteins (A1S_2021-2033), putative acyl carrier pro-
teins, ferric enterobactin receptors, porins, signal pep-
tides, membrane proteins and numerous hypothetical
ORFs with no known function (Fig. 8). Variations in the
expression of multiple potential transcriptional regula-
tors were also observed; this may be due to the signifi-
cant alterations that cAMP levels have on the general
metabolism of the cell. Genes of particular interest in
this study that are down-regulated include the CsuA/
BABCDE system (A1S_2213-2218) (9 to 20-fold), the
hms operon which consists of three genes designated
A1S_2160 to A1S_2162) (10 to12-fold), and a chaperone
usher system (A1S_1507-1510) (2-fold). Proteins
encoded by the csu cluster and chaperone usher system
have been identified in pellicle and biofilm formations
[2, 20, 22, 23, 34, 55, 56]. Interestingly, a single poly-
nucleotide polymorphism leading to truncation of the
csuB gene potentially inactivating this operon has been
identified within ATCC 17978 [2, 22, 56]. Within the
hms operon two proteins (A1S_2160 and A1S_2161)
share an average of 44 % identity with the PgaBC pro-
teins (A1S_0938-0939), the third protein within Hms
(A1S_2162) has been designated as a biofilm synthesis
protein and shares no homology to the Pga proteins in
A. baumannii ATCC 17978. The Pga system has pre-
viously been identified as being important in biofilm for-
mation [57]. Interestingly, a recent paper by Nait Chabane
et al. (2014) [23] found that CsuA/BABCDE, PgaABC
proteins and the chaperone usher system described above,
are over represented within A. baumannii strains display-
ing a pellicle phenotype. This suggests that the Hms and
chaperone usher pilus proteins could be key components
in the formation of the pellicle matrix.
Numerous genes which are up-regulated encode pro-
teins involved in oxidative phosphorylation (Fig. 8). In
particular, these include those encoding ubiquinol oxi-
dase subunit I and II (A1S_1434 and A1S_1433) which
are 5.7- fold and 4.9-fold up-regulated, respectively.
Other genes involved in oxidative phosphorylation in-
clude the NADH dehydrogenase complex (A1S_0762-
0764) and the ATP synthetase complex (A1S_0148-
0156). One of the most highly up-regulated genes
(A1S_1387) is an oxidoreductase (18-fold); this class of
enzymes is often involved in the FAD to FADH2 con-
version, where FADH2 plays a major role in oxidative
phosphorylation. Therefore, many of the up-regulated
genes are involved in the energy, and by extension, the
metabolic status of the cell which is not surprising
given the central role cAMP plays in cell metabolism.
Other genes of interest which were significantly up-
regulated are those involved in 50S and 30S ribosome
assembly. The potential role of these up-regulated
Fig. 8 Differential expression of HiSeq RNA data of cpdA::Tn and 17978hm strains. Comparative whole transcriptome analysis was undertaken on
the cpdA::Tn and 17978hm strains using the Illumina platform. Sequence reads were mapped to the reference ATCC 17978 genome and the
differential gene expression calculated. Diamond markers indicate the differential expression levels of all predicted open reading frames of the
ATCC 17978 genome and are sorted on the x axis according to the locus tag. Changes of 2-fold or more in gene expression were considered
significant, up-regulated genes are identified in red and down-regulated genes in green. Dashed lines indicate 4-fold (log2 = 2) differences in
expression. Genes of particular interest are circled, many of which are discussed in the body of the text
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somes, as these are required for cells to survive long
term nutrient stress in situations where glucose is low
and cAMP is high [58]. Other up-regulated genes in-
cluding those involved in fatty acid oxidation, trehalose
synthase, membrane proteins, dehydrogenase proteins
and a number of proteins which are annotated as hypo-
thetical ORFs.
A small operon consisting of 4 genes (A1S_2088-2091)
was identified as having 4-fold increase in expression. Pro-
teins encoded by this region have recently been found in
extracted pellicle material [23]. Since, cpdA::Tn is not
capable of pellicle production it would seem unlikely that
the A1S_2088-2091 operon is involved in this phenotype,
however, cpdA::Tn does show an increase in biofilm forma-
tion compared to the parent strain and as such this operon
may contribute to liquid/surface biofilm production.
The previously described motility operon A1S_0112-
0118 [47] is up-regulated approximately 3.8-fold in the
cpdA::Tn mutant transcriptome, which is in contrast to
RT-PCR data (Table 3). These RT-PCR studies were con-
ducted on motility agar to look at the influence of motil-
ity on the change in transcription of this operon. Onmotility agar both cAMP and quorum sensing may play
a role in the control of this operon, however in liquid
culture grown to mid-log phase used for the RNA-
sequence analysis, cAMP appears to be solely respon-
sible for the regulation of A1S_0112-0118.
Conclusions
This report has shown that pellicle formation is a
phenotypic trait seen in a limited number of A. bau-
mannii strains. For the first time, the secondary signal-
ling molecule cAMP has been shown to play a critical
role in pellicle formation as well as motility in A. bau-
mannii. Additionally, this study has shown that inser-
tions in CpdA, A1S_0112 and A1S_0115 completely
abolish pellicle formation. Furthermore, transcriptional
analyses identified that cAMP effects the expression of
the A1S_0112-0118 operon essential for motility,
thereby altering the migration pattern seen in the
cpdA::Tn mutant strain grown on semi-sold agar; inser-
tions in the above operon in A1S_0112 and A1S_0115
resulted in a non-motile phenotype. We thus speculate,
that pellicle and motility phenotypes of A. baumannii
are linked via the expression of cAMP and the
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phobicity was identified as an indicator of pellicle for-
mation ability in the clinical strains tested herein.
Whole transciptome analysis has identified an abun-
dance of ORFs affected by the increase in cAMP within
the cpdA::Tn mutant. A number of these correlate with
genes previously known to be involved in pellicle forma-
tion including the hms locus and a chaperone usher sys-
tem as well as the A1S_0112-0118 region identified in
this study. Considering the importance of pellicle for-
mation in the persistence and transmission of numerous
bacterial species, this study has contributed to our un-
derstanding of the regulatory mechanisms behind these
significant virulence traits in A. baumannii.Methods
Bacterial strains
The 54 clinical A. baumannii bacterial strains used in
this study and the hyper-motile derivative of A. bau-
mannii ATCC 17978 designated 17978hm have been
described previously [34, 59]. All A. baumannii strains
were cultured on LB media containing 1 % agar over-
night at 37 °C, and single colonies transferred to LB
broth for subsequent use in assays, unless otherwise
stated. For maintenance, conjugation, cloning and repli-
cating plasmids E. coli DH5α, SM10 or JM109 cells
were used [60–62].Assessment of pellicle formation
The pellicle formation assay was adapted from previously
described protocol [35]. In brief, overnight bacterial cul-
tures were diluted 1:100 in 5 mL of LB broth and grown
stagnant in polypropylene or glass tubes for 72 h at 25 °C
without shaking in the dark [63, 64]. Quantitative measure-
ment of the pellicle material was assessed by the addition
of 1 mL of ethanol into the tube underneath the pellicle
material. The floating pellicle was then removed and resus-
pended in phosphate buffered saline (PBS) and the OD600
measured using a spectrophotometer (Beckman DU 640).
Quantitative data were collected from at least three experi-
ments on three different days.Motility assays
Motility was assessed by migration on semi-solid sur-
faces using media containing 0.25 % agar as described
previously [34]. Briefly, an overnight colony was col-
lected using a sterile loop and used to inoculate the
centre of LB medium containing 0.25 % agar. The plate
was then incubated overnight at 37 °C. Strains were con-
sidered motile if any movement of growth from the ori-
ginal inoculation site was observed.Eukaryotic cell adherence assays
A. baumannii cell adherence to A549 (human type 2
pneumocytes) was investigated as previously described
[34]. In brief, cell lines were grown in Dulbecco’s Modi-
fied Eagle medium (Invitrogen, Australia) supplemented
with 10 % foetal bovine serum (Bovogen, Australia).
Washed A549 monolayers in 24-well tissue culture
plates were infected with bacterial inoculums contain-
ing ~1x107 colony forming units. After incubation at
37 °C for 4 h the culture medium was removed and the
monolayers washed with PBS. The cell monolayers were
detached from the plate using a treatment of 100 μL of
0.25 % trypsin in PBS. Eukaryotic cells were subsequently
lysed by the addition of 400 μL 0.025 % Triton X-100 and
serial 10-fold dilutions were spread plated on LB agar to
determine the number of colony forming units of adher-
ent bacteria per well. The collated data for the adherence
assay were obtained from at least three independent ex-
periments and represent the data points from each experi-
ment in quadruplicate wells.Cell surface hydrophobicity tests
Cell surface hydrophobicity was examined as described
previously [65]. In brief, overnight cultures were diluted
in LB broth and incubated at 37 °C for 2 h. Potassium
urea magnesium buffer was used to wash the cells twice,
before incubation at 30 °C for 20 min. The cell suspension
was adjusted to OD600 ~ 0.25 in the same buffer in glass
vials before the addition of xylene (3 mL). The sample was
vortexed for 20 sec and the aqueous phase transferred to a
1.5 mL tube. The OD600 of the cell suspension was deter-
mined before (ODinitial) and after (ODfinal) the addition of
xylene. The hydrophobicity index, expressed as a percent-
age, is calculated as (ODinital −ODfinal/ODinitial)*100.
Quantitative data were collected from at least three exper-
iments from three different days.Transposon mutagenesis
Transposon mutagenesis was undertaken using a modi-
fied mini Tn10 transposon (mini::Tn10:gfp:kan) carried
on the plasmid pLof [66]. The pLof mini::Tn10:gfp:kan
plasmid was transformed into the donor E. coli SM10
strain and mated with the A. baumannii 17978hm re-
cipient at a 1:10 ratio for 4 h at 37 °C on LB agar excon-
jugates were resuspended in 5 mL of LB broth and
plated onto selective media containing 50 μg/mL kana-
mycin and 25 μg/mL chloramphenicol to select for
transposition events and counter-select against the E.
coli SM10 donor strain. Approximately, 4000 exconju-
gates were individually picked using sterile toothpicks to
inoculate 200 μL of LB broth in 96 well microtitre plates.
The cells were grown at 25 °C in the dark for 72 h and
assessed visually for pellicle loss.
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chromosome
Chromosomal DNA isolated from A. baumannii 17978hm
containing the mini::Tn10:gfp:kan was digested with re-
striction endonucleases XbaI and SacII for 4 h at 37 °C.
Digested products were cloned into pBluescript SK II (Agi-
lent technologies, CA, USA) and clones were confirmed by
sequencing (Australian Genome Research Facility,
Adelaide, South Australia). The insertion site of the
transposons in the chromosome was determined by
Sanger sequencing using an oligonucleotide designed to
read out of the end of the transposon (see Additional
file 2).
Complementation of transposon insertions
For genetic complementation of the non-pellicle forming
A. baumannii mutants, the genes corresponding to
A1S_0112, A1S_0115 and cpdA were PCR amplified,
cloned into the shuttle vector pWH1266, transformed
into DH5α E. coli cells and sequenced. Plasmids were
extracted and subsequently transformed via electropor-
ation using a MicroPulser (Bio-Rad, CA, USA) at 2.5 kV,
200 ohms and 25 microfarads into their respective A.
baumannii transposon insertion strains [46]. PCR was
achieved with VELOCITY™ DNA polymerase (Bioline,
Vic, Australia) and the oligonucleotides (Additional file
2) using the following PCR protocols. For amplification
of cpdA, cycling conditions were 2 min at 94 °C, 30 cy-
cles of 45 sec at 94 °C, 45 sec at 55 °C, and 90 sec at
72 °C, followed by a final extension of 4 min at 72 °C.
Amplification of A1S_0112 used the same conditions
with the exception of the annealing temperature which
was increased to 60 °C. For amplification of A1S_0115,
the cycling conditions were 2 min at 94 °C, 30 cycles of
90 sec at 94 °C, 90 sec at 60 °C, 4 min at 72 °C and a
final extension of 6 min at 72 °C.
Measurement of intracellular cAMP levels
Assessment of cAMP levels within A. baumannii strains
cpdA::Tn, cpdA::Tn(0249), cpdA::Tn(1266) and 17978hm
was performed with cells were grown to an OD600 of
0.7. Cells were pelleted by centrifugation at 4500 g for
15 min, resuspended in PBS and disrupted at 30,000 lb
per square inch using the One Shot Head from the TS
series bench top disruptor (Constant Systems, United
Kingdom). The resulting cellular material in the cell lysis
solution was clarified by centrifugation at 4500 g for 30
min and the supernatant removed and stored at −80 °C
until required. The concentration of cAMP was mea-
sured using the Cyclic Nucleotide XP Enzymatic Im-
munoassay kit (Cell Signalling Technology, MA, USA)
according to the manufacturer’s instructions. In brief, 50
μL of horseradish peroxidase-linked cAMP solution and
50 μL of sample were added to the supplied 96-well tray,which was then covered and incubated at room
temperature for 3 h on a horizontal orbital plate shaker.
The contents of the plate were discarded and the plate
was washed 4 times with 200 μL/well of wash buffer.
Next, 100 μL of 3,3′,5,5′-tetramethylbenzidinesubstrate
solution was added and incubated for 30 min at room
temperature, after which 100 μL of stop solution was
added and the absorbance measured at 450 nm. Using
the inverse for the standards derived from a standard
curve and adjusted for the amount of total protein
added, the amount of cAMP was calculated. Total pro-
tein concentrations were quantified using the Lowry
protein assay (Bio-Rad, CA, USA) following the manu-
facturer’s instructions.
Isolation of total cellular RNA
To measure transcriptional levels for either RT-PCR or
in Hiseq RNA transcriptome analysis conducted by SA
Pathology (Central Adelaide local Health Network via an
Illumina platform), cells were isolated and RNA ex-
tracted as below. Bacterial cells were harvested from ei-
ther semi-solid media (0.25 % LB agar) for RT-PCR
using pre-chilled PBS or harvested from Mueller Hinton
broth at OD600 of 0.6 for Hiseq. Bacterial cells were pel-
leted by centrifugation at 4500 g for 15 min and lysed in
1 mL TRIzol reagent (Life Technologies, Australia) and
200 μL of chloroform. Following phase separation, the
aqueous layer was collected and RNA isolated using the
Isolate RNA Mini Kit (Bioline, NSW, Australia) follow-
ing the manufacturer’s recommendations. Samples for
RT-PCR were subsequently treated with DNaseI (Pro-
mega, WI, USA) for 30 min at 37 °C and 1 μL of stop
solution was added before a final incubation for 10 min
at 65 °C. Triplicate samples were pooled and sent to SA
Pathology for Ribosomal RNA reduction using Epicentre
Ribo-Zero kit and RNA library bar-coding was under-
taken on RNA for HiSeq. Samples were run on the Illu-
mina HiSeq platform (1X50 base pair single reads).




The quality of the cDNA reads obtained from the HiSeq
was checked using ‘Fastqc’ (http://www.bioinformatics.-
babraham.ac.uk/projects/fastqc/). Reads were subsequently
mapped to the reference genome using ‘bowtie’ aligner
(http://bowtie-bio.sourceforge.net/index.shtml). For the
reads obtained, approximately 95 % were mapped to
the ATCC 17978 genome of which 78 % mapped to the
coding regions. In order to determine changes in gene
expression the number of reads obtained for each ORF
was normalised using reads per kilobase of transcript
per million reads mapped.
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M-MLV reverse-transcriptase (Promega) and random
hexamers (GeneWorks, SA, Australia) were used to syn-
thesise complementary deoxyribonucleic acid (cDNA)
following the manufacturer’s recommendations. qRT-
PCR was performed on three biological replicates using
DyNAmo SYBR green qRT-PCR kits (ThermoScientific,
Vic, Australia) in conjunction with a Rotor-Gene RG-
3000 (Corbett Life Science, Australia). A typical qRT-
PCR run was as follows: 1 min at 95 °C, 40 cycles of 10
sec at 95 °C, 15 sec at 55 °C and 20 sec at 72 °C [67].
Transcriptional differences were calculated using the
ΔΔCT method [68]. The 16S rRNA (A1S_r01) and
gapDH (A1S_2501) transcription levels were used as a
reference.
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